IRIS UniCatt

Sora', Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.186
AS - Asia 5.498
EU - Europa 4.612
SA - Sud America 1.106
AF - Africa 172
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.592
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.021
SG - Singapore 2.551
CN - Cina 1.311
DE - Germania 1.287
BR - Brasile 905
IT - Italia 777
SE - Svezia 731
VN - Vietnam 490
FR - Francia 464
GB - Regno Unito 282
IE - Irlanda 253
IN - India 230
UA - Ucraina 201
FI - Finlandia 191
ID - Indonesia 181
JP - Giappone 129
RU - Federazione Russa 126
HK - Hong Kong 92
TR - Turchia 77
AR - Argentina 75
BD - Bangladesh 73
KR - Corea 73
CA - Canada 68
NL - Olanda 60
MX - Messico 59
IQ - Iraq 53
PL - Polonia 37
AT - Austria 32
SA - Arabia Saudita 32
CI - Costa d'Avorio 30
BE - Belgio 29
EC - Ecuador 29
ES - Italia 29
UZ - Uzbekistan 28
ZA - Sudafrica 28
IR - Iran 27
MA - Marocco 27
CZ - Repubblica Ceca 23
CO - Colombia 21
PK - Pakistan 21
KE - Kenya 20
EG - Egitto 19
VE - Venezuela 18
CL - Cile 16
PH - Filippine 14
UY - Uruguay 14
JO - Giordania 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
CH - Svizzera 12
IL - Israele 12
LT - Lituania 12
PY - Paraguay 12
AL - Albania 10
HU - Ungheria 10
NP - Nepal 10
PE - Perù 10
TN - Tunisia 10
AU - Australia 9
DZ - Algeria 9
RO - Romania 8
LB - Libano 7
AO - Angola 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
JM - Giamaica 6
OM - Oman 6
PA - Panama 6
BG - Bulgaria 5
EE - Estonia 5
MY - Malesia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
BZ - Belize 4
CR - Costa Rica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PT - Portogallo 4
QA - Qatar 4
TH - Thailandia 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GR - Grecia 3
LI - Liechtenstein 3
MD - Moldavia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
GA - Gabon 2
GY - Guiana 2
HN - Honduras 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
SV - El Salvador 2
Totale 17.562
Salva come PNG Salva come JPEG
Città #
Singapore 1.332
Ashburn 694
San Jose 679
Chandler 639
Beijing 257
Dublin 249
Hefei 200
Woodbridge 179
Los Angeles 168
Lauterbourg 161
Jakarta 160
Jacksonville 157
Ho Chi Minh City 156
Rome 149
San Mateo 137
Hanoi 126
Dearborn 125
Tokyo 123
Nanjing 112
Wilmington 112
Frankfurt am Main 110
Milan 107
Munich 107
New York 101
Houston 99
Fairfield 90
Hyderabad 87
Ann Arbor 84
Helsinki 84
Hong Kong 83
The Dalles 81
Chicago 80
Seattle 75
Boston 74
Council Bluffs 73
Cattolica 71
Moscow 71
Seoul 67
São Paulo 67
Florence 63
Princeton 58
Buffalo 57
Redmond 57
Santa Clara 57
Dallas 56
St Louis 56
Kent 55
Nürnberg 53
Lancaster 52
Nanchang 51
Redwood City 50
Marseille 49
Lappeenranta 43
Lawrence 41
Paris 41
Bremen 39
Izmir 36
Orem 36
Atlanta 34
London 31
Abidjan 30
Brussels 29
Rio de Janeiro 28
Nuremberg 27
Warsaw 27
Da Nang 26
Shanghai 26
Kunming 25
Dhaka 24
Tashkent 24
Brooklyn 23
Norwalk 23
Tianjin 23
Toronto 23
Belo Horizonte 22
Guangzhou 22
Amsterdam 21
Boardman 21
Baghdad 20
Manchester 19
Phoenix 19
Stockholm 19
Düsseldorf 18
Pune 18
San Francisco 18
Hangzhou 17
Leawood 17
Nairobi 17
Turku 17
Cambridge 16
Campinas 16
Curitiba 16
Haiphong 16
Mexico City 16
Mountain View 16
Porto Alegre 16
Vienna 16
Auburn Hills 15
Brno 15
Montreal 15
Totale 9.357
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 432
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 373
Dasatinib first-line: Multicentric Italian experience outside clinical trials 295
Dasatinib first-line: Multicentric Italian experience outside clinical trials 294
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 290
Correlation between paraproteinaemia and viral reactivation after allo-SCT 215
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 209
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 187
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 177
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 176
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 175
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 172
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 169
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 164
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 157
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 156
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 153
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 149
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 148
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 147
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 147
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 145
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 143
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 142
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 141
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 140
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 136
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 135
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 132
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 131
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 129
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 127
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 127
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 126
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 125
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 125
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 123
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 123
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 121
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 121
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 120
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 120
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival 118
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 117
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review 115
Unrelated cord blood transplantation and post-transplant cyclophosphamide 115
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 113
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 113
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 112
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 111
the concomitance of lymphoma and breast carcinoma in the bone 111
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 110
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 109
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 109
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 108
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 107
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study 107
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study 106
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 106
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 106
CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL) 106
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 106
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 105
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 104
Second haploidentical stem cell transplantation for primary graft failure 104
Coagulopathy in CAR-T: Critical concern or mere blip? 103
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 102
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 102
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 102
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 101
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 100
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients 100
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 99
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 99
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 96
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 96
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 95
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 95
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 95
Unrelated cord blood transplantation and post-transplant cyclophosphamide 95
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline 94
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study 94
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 93
Chronic myeloid leukaemia with extreme thrombocytosis at presentation: Incidence, clinical findings and outcome 93
Treatment patterns in patients with chronic-phase chronic myeloid leukaemia in routine clinical practice: The simplicity Italian population 93
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib 92
allogenic hemopoietic stem cell transplant in patients with acute myeloid leukemia prepared with busulfan and fludarabine or thiotepa busulfan and fludarabine a retrospective study 92
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center 90
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry 90
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 89
next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome -positive acute lymphoblastic leukemia 89
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 89
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 89
The concomitance of lymphoma and breast carcinoma in the bone 89
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 89
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 88
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 88
Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party 88
Totale 13.025
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.307
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021131 0 0 0 0 0 0 0 0 0 0 113 18
2021/2022916 76 39 34 41 65 24 18 139 49 62 181 188
2022/20232.043 254 244 148 252 209 274 95 150 257 51 82 27
2023/20241.297 42 353 58 88 43 152 98 77 26 69 121 170
2024/20253.255 98 80 217 173 255 117 115 133 435 313 746 573
2025/20266.865 1.115 231 465 740 1.114 408 1.212 429 503 585 63 0
Totale 17.921